These outcomes, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the notion of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-associated disorders. Publishing this evaluation means that you https://charlesz405stl9.bloginder.com/profile